IGC Pharma Inc (IGC) Beta and Market Comparison: S&P500 vs IGC

After finishing at $0.38 in the prior trading day, IGC Pharma Inc (AMEX: IGC) closed at $0.34, down -8.91%. In other words, the price has decreased by -$0.0337 from its previous closing price. On the day, 2418594 shares were traded.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Ratios:

Our goal is to gain a better understanding of IGC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGC now has a Market Capitalization of 21.96M and an Enterprise Value of 20.96M. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.00 while its Price-to-Book (P/B) ratio in mrq is 2.43. Its current Enterprise Value per Revenue stands at 17.23 whereas that against EBITDA is -1.90.

Stock Price History:

Over the past 52 weeks, IGC has reached a high of $0.50, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 0.3048, while the 200-Day Moving Average is calculated to be 0.3226.

Shares Statistics:

The stock has traded on average 419.97K shares per day over the past 3-months and 664.62k shares per day over the last 10 days, according to various share statistics. A total of 63.73M shares are outstanding, with a floating share count of 56.73M. Insiders hold about 10.98% of the company’s shares, while institutions hold 3.87% stake in the company. Shares short for IGC as of Feb 29, 2024 were 910.73k with a Short Ratio of 2.17, compared to 961.25k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.43% and a Short% of Float of 1.52%.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.

Analysts are recommending an EPS of between -$0.22 and -$0.22 for the fiscal current year, implying an average EPS of -$0.22. EPS for the following year is -$0.16, with 1 analysts recommending between -$0.16 and -$0.16.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $1.4M in the next fiscal year. The high estimate is $1.4M and the low estimate is $1.4M. The average revenue growth estimate for next year is up 12.90% from the average revenue estimate for this year.

Most Popular